These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6064457)

  • 21. [An unusual form of benign hereditary recessive x-chromosomal muscular dystrophy].
    Rotthauwe HW; Beyer H
    Monatsschr Kinderheilkd (1902); 1970 Jun; 118(6):410. PubMed ID: 5523692
    [No Abstract]   [Full Text] [Related]  

  • 22. Fortuitous detection of a sporadic carrier of Duchenne's muscular dystrophy.
    Hanson JW; Zellweger H; Afifi AK; McCormick WF
    Humangenetik; 1968; 6(1):34-9. PubMed ID: 5699892
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical studies in progressive muscular dystrophy.
    Prot J
    Pol Med J; 1972; 11(4):1004-12. PubMed ID: 5078704
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical polymorphism and genetic heterogeneity in Duchenne's progressive muscular dystrophy in girls (a review)].
    Zavadenko NN; Temin PA; Malygina NA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(11):123-6. PubMed ID: 3066079
    [No Abstract]   [Full Text] [Related]  

  • 25. [Surgical management of contractures in Duchenne's muscular dystrophy. Review of 30 patients].
    Roy L
    Rev Chir Orthop Reparatrice Appar Mot; 1971; 57(5):339-54. PubMed ID: 4257956
    [No Abstract]   [Full Text] [Related]  

  • 26. Dystrophin assay in muscular dystrophies: an Indian experience.
    Jain S; Sarkar C; Dinda AK; Maheshwari MC
    Natl Med J India; 1993; 6(6):259-62. PubMed ID: 7950930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Xeroradiographic examination in the study of Duchenne's progressive muscular dystrophy. Correlation of the radiological data with the clinical and laboratory findings].
    Calandi C; Adami Lami Conti C; Fronzoni S; Nistri R; Rossini F; Aulisi A
    Minerva Pediatr; 1980 Mar; 32(5):283-9. PubMed ID: 7382944
    [No Abstract]   [Full Text] [Related]  

  • 28. [Evaluation of serum pyruvate kinase in patients with Duchenne's muscular dystrophy and carriers. Comparison with other enzyme determinations].
    Calandi C; Adami Lami C; Guidotti T; Nistri R; Papuzza S; Tozzi P; Poggi G
    Minerva Pediatr; 1981 May; 33(10):453-64. PubMed ID: 7254147
    [No Abstract]   [Full Text] [Related]  

  • 29. [Electrocardiographic study of progressive muscular dystrophy Duchenne's type].
    De los Arcos E; Sánchez Cascos A; De Rábago P
    Rev Esp Cardiol; 1969; 22(2):193-200. PubMed ID: 5801957
    [No Abstract]   [Full Text] [Related]  

  • 30. [Duchenne's muscular dystrophy in a girl with 45,X/46,XX chromosomal mosaicism].
    Aver'ianov IuN; Bogomazov EA; Logunova LV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(10):1449-52. PubMed ID: 930487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [AMP-aminohydrolase of skeletal muscles in muscular diseases].
    Niebrój-Dobosz I; Strumień M
    Neurol Neurochir Pol; 1979; 13(4):383-7. PubMed ID: 481690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study of the kinetics of anion metabolism in the erythrocytes of patients with various forms of hereditary neuromuscular diseases].
    Sitnikov VF; Khrennikov VIu; Sidorov EP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(11):1617-20. PubMed ID: 3434056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mosaic expression of dystrophin in symptomatic carriers of Duchenne's muscular dystrophy.
    Arahata K; Ishihara T; Kamakura K; Tsukahara T; Ishiura S; Baba C; Matsumoto T; Nonaka I; Sugita H
    N Engl J Med; 1989 Jan; 320(3):138-42. PubMed ID: 2643040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Duchenne's muscular dystrophy: socioreligious belief delays diagnosis and genetic counselling.
    Lyn PC
    Singapore Med J; 1986 Feb; 27(1):68-71. PubMed ID: 3715493
    [No Abstract]   [Full Text] [Related]  

  • 35. [The problem of Duchenne's muscular dystrophy in young girls. Apropos of a case].
    Buscaino GA; Marolda M; Cafiero L; Borgia G
    Acta Neurol (Napoli); 1981 Feb; 3(1):154-6. PubMed ID: 7246288
    [No Abstract]   [Full Text] [Related]  

  • 36. Myoblast transfer in the treatment of Duchenne's muscular dystrophy.
    Mendell JR; Kissel JT; Amato AA; King W; Signore L; Prior TW; Sahenk Z; Benson S; McAndrew PE; Rice R
    N Engl J Med; 1995 Sep; 333(13):832-8. PubMed ID: 7651473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Plasma lipids of patients with Duchenne's muscular dystrophy at different stages of the disease].
    Temin PA; Islamova IB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(11):1632-6. PubMed ID: 6675360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical symptoms in a female carrier of Duchenne muscular dystrophy.
    Zatz M; Levisky RB; Levy JA; Valente BO; Gianotti M; Frota-Pessoa O
    J Genet Hum; 1973 Dec; 21(4):297-305. PubMed ID: 4792239
    [No Abstract]   [Full Text] [Related]  

  • 39. [Evaluation of fine neuromuscular control in Duchenne's progressive muscular dystrophy I. A basic and clinical study in the rehabilitation of 10 non-ambulatory patients].
    Simard T
    Union Med Can; 1982 Jun; 111(6):569-74. PubMed ID: 7112753
    [No Abstract]   [Full Text] [Related]  

  • 40. Family in which Duchenne's muscular dystrophy and protan colour blindness are segregating.
    Greig DN
    J Med Genet; 1977 Apr; 14(2):130-2. PubMed ID: 300790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.